3737.HK Stock Analysis
37
Uncovered
Zhongzhi Pharmaceutical Holdings Ltd is uncovered by Eyestock quantitative analysis.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Moderate score
Zhongzhi Pharmaceutical Holdings Ltd. engages in the manufacture and sale of pharmaceutical products. The company is headquartered in Zhongshan, Guangdong and currently employs 2,849 full-time employees. The company went IPO on 2015-07-13. The firm is principally engaged in the research and development, manufacturing and sales of Chinese patent medicines and decoction pieces (consisting of traditional decoction pieces and modern decoction pieces). The firm operates through three segments: pharmaceutical manufacturing segment, operation of chain pharmacies in Zhongshan, Guangdong Province and operation of on-line pharmacies. The Company’s brands include Zeus, Liumian and Caojinghua. The firm mainly conducts its businesses in the domestic market.